University of Alabama at Birmingham, Birmingham, AL, USA.
Kaiser Permanente Southern California, Pasadena, CA, USA.
Sleep. 2022 May 12;45(5). doi: 10.1093/sleep/zsac063. Epub 2022 Mar 11.
Insomnia is common among older adults and associated with an increased risk for falls. Determining if falls are more strongly associated with insomnia or prescribed hypnotic medications could be used to guide interventions to reduce falls risk.
We examined the prospective association of a diagnosis of insomnia and/or prescribed hypnotic medication use with the risk for serious fall injuries among 9087 Reasons for Geographic and Racial Differences in Stroke (REGARDS) study participants aged 65 years or older with Medicare fee-for-service health insurance at baseline (2003-2007). A diagnosis of insomnia was based on ICD-9 codes in Medicare claims and prescribed hypnotic medication use was determined through a pill bottle review. Serious fall injuries were identified by Medicare claims between baseline and December 31, 2018.
Over a median of 6.8 years, 1660 (18.3%) participants had a serious fall injury. The incidence rates for a serious fall injury per 1000 person-years were 24.8 (95%CI: 23.5, 26.1), 28.8 (95%CI: 18.6, 38.9), 32.6 (95%CI: 28.2, 37.0), and 46.6 (95%CI: 26.7, 66.5) for participants without insomnia or taking prescribed hypnotic medication (-insomnia/-hypnotics), with insomnia only (+insomnia/-hypnotics), taking prescribed hypnotic medication only (-insomnia/+hypnotics), and with insomnia and taking prescribed hypnotic medication (+insomnia/+hypnotics), respectively. Compared with the -insomnia/-hypnotic group, the multivariable-adjusted hazard ratios for a serious fall injury were 1.13 (95%CI: 0.79, 1.61), 1.29 (95%CI: 1.11, 1.50), and 1.60 (95%CI: 1.01, 2.56) for +insomnia/-hypnotics, -insomnia/+hypnotics, and +insomnia/+hypnotics, respectively.
The risk for serious fall injuries was higher for those taking prescribed hypnotic medications but not with an insomnia diagnosis.
失眠在老年人中很常见,且与跌倒风险增加相关。确定跌倒与失眠或处方催眠药物的相关性,可用于指导干预措施以降低跌倒风险。
我们研究了在基线时(2003-2007 年)拥有医疗保险费制健康保险且年龄在 65 岁或以上的 9087 名 Reasons for Geographic and Racial Differences in Stroke(REGARDS)研究参与者中,失眠的诊断和/或处方催眠药物的使用与严重跌倒伤害风险之间的前瞻性关联。失眠的诊断是基于医疗保险索赔中的 ICD-9 代码,而处方催眠药物的使用则通过药瓶审查确定。严重跌倒伤害通过医疗保险索赔在基线至 2018 年 12 月 31 日期间确定。
在中位时间为 6.8 年期间,有 1660 名(18.3%)参与者发生严重跌倒伤害。每 1000 人年发生严重跌倒伤害的发生率分别为 24.8(95%CI:23.5,26.1)、28.8(95%CI:18.6,38.9)、32.6(95%CI:28.2,37.0)和 46.6(95%CI:26.7,66.5),参与者分为无失眠或服用处方催眠药物组(无失眠/无催眠药)、仅失眠组(失眠/无催眠药)、仅服用处方催眠药物组(无失眠/催眠药)和失眠且服用处方催眠药物组(失眠/催眠药)。与无失眠/无催眠药组相比,严重跌倒伤害的多变量调整后的危险比分别为 1.13(95%CI:0.79,1.61)、1.29(95%CI:1.11,1.50)和 1.60(95%CI:1.01,2.56)。
服用处方催眠药物与严重跌倒伤害风险增加相关,但失眠诊断则无关。